Akihito Todate
Hamamatsu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Akihito Todate.
Journal of the American Geriatrics Society | 2006
Tateaki Naito; Takafumi Suda; Kazumasa Yasuda; Takashi Yamada; Akihito Todate; Tomoyoshi Tsuchiya; Jun Sato; Kingo Chida; Hirotoshi Nakamura
OBJECTIVES: To evaluate the discriminatory power of the Pneumonia Severity Index (PSI) in elderly patients with community‐acquired pneumonia (CAP) and to improve its performance.
Respirology | 2002
Hiroshi Hayakawa; Masahiro Shirai; Atsuhiko Sato; Yasuyuki Yoshizawa; Akihito Todate; Shiro Imokawa; Takafumi Suda; Kingo Chida; Ryoji Tamura; Kyousuke Ishihara; Shigeki Saiki; Masayuki Ando
Objective: Only limited information exists concerning the clinical and pathological features of chronic hypersensitivity pneumonitis (HP) in Japan and elsewhere. We present data on clinicopathological features of chronic HP obtained through a Japanese nationwide survey.
Journal of Leukocyte Biology | 2001
Akihito Todate; Takafumi Suda; Hiroshi Kuwata; Kingo Chida; Hirotoshi Nakamura
Muramyl dipeptide (MDP)‐Lys (L18), a synthetic MDP analogue derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune‐competent cells, such as monocytes and macrophages. However, it is not known whether MDP‐Lys modulates the function of dendritic cells (DCs), which are the most potent antigen‐presenting cells and play a crucial role in initiating T cell‐mediated immunity. Therefore, we examined the effects of MDP‐Lys on the expression of surface molecules, cytokine production, and antigen‐presenting function of human DCs generated from peripheral blood cells in the presence of interleukin (IL)‐4 and granulocyte‐macrophage colony‐stimulating factor. We found that MDP‐Lys markedly up‐regulated the expression of CD80, CD83, CD86, and CD40, but not human leukocyte antigen‐DR, and stimulated the production of tumor necrosis factor‐α, IL‐6, IL‐8, IL‐10, and IL‐12 (p40) by human DCs in a dose‐dependent manner. Furthermore, MDP‐Lys‐treated DCs showed enhanced antigen‐presenting function compared with untreated DCs, as assessed by an allogeneic mixed lymphocyte reaction. These results suggested that the immunoadjuvant activity of MDP‐Lys in vivo is mediated, in part, by its stimulation of DC function.
Cytokine | 2002
Takafumi Suda; Kingo Chida; Akihito Todate; Kyotaro Ide; Kazuhiro Asada; Yutaro Nakamura; Kenichiro Suzuki; Hirofumi Kuwata; Hirotoshi Nakamura
American Journal of Respiratory and Critical Care Medicine | 2000
Akihito Todate; Kingo Chida; Takafumi Suda; Shiro Imokawa; Jun Sato; Kyotaro Ide; Tomoyoshi Tsuchiya; Naoki Inui; Yutaro Nakamura; Kazuhiro Asada; Hiroshi Hayakawa; Hirotoshi Nakamura
Internal Medicine | 1998
Hiroshi Hayakawa; Atsuhiko Sato; Shiro Imokawa; Akihito Todate; Kingo Chida; Kazuya Suzuki; Masatoshi Iwata
The Japanese journal of thoracic diseases | 1997
Mikio Toyoshima; Atsuhiko Sato; Kingo Chida; Hiroshi Hayakawa; Akihito Todate; Shiro Imokawa; Masatoshi Iwata; Hiroyuki Ohashi; Masahiro Shirai; Hiroshi Yagi
The journal of the Japanese Respiratory Society | 1999
Inui N; Kingo Chida; Takafumi Suda; Mikio Toyoshima; Akihito Todate; Ide K; Tsukamoto K; Jun Sato; Tsuchiya T; Hirotoshi Nakamura
The journal of the Japanese Respiratory Society | 2000
Nakamura Y; Kingo Chida; Takafumi Suda; Akihito Todate; Hiroshi Hayakawa; Masatoshi Iwata; Shiro Imokawa; Genma H; Yasuda K; Takeshi Yagi; Tamura R; Shirai T; Hirata T; Yanase K; Hirotoshi Nakamura
The journal of the Japanese Respiratory Society | 1998
Inui N; Kingo Chida; Takafumi Suda; Mikio Toyoshima; Akihito Todate; Ide K; Tsukamoto K; Jun Sato; Tsuchiya T; Hirotoshi Nakamura